TetO-FUW-PBRM1-pgk-puro Citations (5)

Originally described in: PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.
Chowdhury B, Porter EG, Stewart JC, Ferreira CR, Schipma MJ, Dykhuizen EC PLoS One. 2016 Apr 21;11(4):e0153718. doi: 10.1371/journal.pone.0153718. eCollection 2016. PubMed Journal

---

Articles Citing TetO-FUW-PBRM1-pgk-puro

Articles
CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells. Lin P, Qin S, Pu Q, Wang Z, Wu Q, Gao P, Schettler J, Guo K, Li R, Li G, Huang C, Wei Y, Gao GF, Jiang J, Wu M. Mol Cell. 2020 Jun 4;78(5):850-861.e5. doi: 10.1016/j.molcel.2020.03.033. Epub 2020 Apr 28. PubMed
PBRM1 bromodomains associate with RNA to facilitate chromatin association. De Silva SM, Dhiman A, Sood S, Mercedes KF, Simmons WJ, Henen MA, Vogeli B, Dykhuizen EC, Musselman CA. Nucleic Acids Res. 2023 May 8;51(8):3631-3649. doi: 10.1093/nar/gkad072. PubMed
Multi-omics integration identifies cell-state-specific repression by PBRM1-PIAS1 cooperation. Ho PJ, Kweon J, Blumensaadt LA, Neely AE, Kalika E, Leon DB, Oh S, Stringer CWP, Lloyd SM, Ren Z, Bao X. Cell Genom. 2024 Jan 10;4(1):100471. doi: 10.1016/j.xgen.2023.100471. Epub 2024 Jan 2. PubMed
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppression. Bursch KL, Goetz CJ, Jiao G, Nunez R, Olp MD, Dhiman A, Khurana M, Zimmermann MT, Urrutia RA, Dykhuizen EC, Smith BC. J Biol Chem. 2024 Apr;300(4):107146. doi: 10.1016/j.jbc.2024.107146. Epub 2024 Mar 7. PubMed
PARP inhibition-associated heterochromatin confers increased DNA replication stress and vulnerability to ATR inhibition in SMARCA4-deficient cells. Yano K, Kato M, Endo S, Igarashi T, Wada R, Kohno T, Zimmermann A, Dahmen H, Zenke FT, Shiotani B. Cell Death Discov. 2025 Jan 28;11(1):31. doi: 10.1038/s41420-025-02306-1. PubMed

If you have published an article using this material, please email us at to have your article added to this page.